Sign inGet started

OSBORNE DAVID W

Insider CIK 1252999 · ARQT Chief Technical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ARQT Arcutis Biotherapeutics, I S Sale2023-03-062023-03-08690$15.26 $10.5K268,854SEC↗
ARQT Arcutis Biotherapeutics, I A Award deriv2023-03-022023-03-0639,500— $039,500SEC↗
ARQT Arcutis Biotherapeutics, I S Sale2023-03-022023-03-0215$16.52 $248254,644SEC↗
ARQT Arcutis Biotherapeutics, I S Sale2023-03-022023-03-021,198$15.82 $19.0K254,659SEC↗
ARQT Arcutis Biotherapeutics, I A Award2023-03-022023-03-0614,900— $0269,544SEC↗
ARQT Arcutis Biotherapeutics, I S Sale2023-02-282023-03-02792$16.17 $12.8K255,857SEC↗
ARQT Arcutis Biotherapeutics, I S Sale2022-07-082022-07-122,197$25.41 $55.8K256,649SEC↗
ARQT Arcutis Biotherapeutics, I S Sale2022-04-212022-04-212,197$20.42 $44.9K257,229SEC↗
ARQT Arcutis Biotherapeutics, I S Sale2022-03-072022-03-0728$16.44 $460259,426SEC↗
ARQT Arcutis Biotherapeutics, I S Sale2022-03-042022-03-07828$16.86 $14.0K259,454SEC↗
ARQT Arcutis Biotherapeutics, I A Award deriv2022-03-032022-03-0735,300— $035,300SEC↗
ARQT Arcutis Biotherapeutics, I A Award2022-03-032022-03-0713,300— $0260,282SEC↗
ARQT Arcutis Biotherapeutics, I S Sale2022-03-012022-03-03775$17.75 $13.8K246,982SEC↗
ARQT Arcutis Biotherapeutics, I A Award deriv2021-03-032021-03-0528,800— $028,800SEC↗
ARQT Arcutis Biotherapeutics, I A Award2021-03-032021-03-059,500— $0246,753SEC↗
ARQT Arcutis Biotherapeutics, I S Sale2021-03-012021-03-03780$34.57 $27.0K237,253SEC↗
ARQT Arcutis Biotherapeutics, I S Sale2020-12-142020-12-1615,000$30.00 $450.0K250,533SEC↗
ARQT Arcutis Biotherapeutics, I S Sale2020-09-292020-10-0115,000$30.00 $450.0K264,279SEC↗
ARQT Arcutis Biotherapeutics, I A Award deriv2020-02-272020-03-0312,000— $012,000SEC↗
ARQT Arcutis Biotherapeutics, I A Award2020-02-272020-03-039,000— $0279,279SEC↗
ARQT Arcutis Biotherapeutics, I C Conversion deriv2020-02-042020-02-0424,991— $00SEC↗
ARQT Arcutis Biotherapeutics, I C Conversion2020-02-042020-02-0424,991— $0270,279SEC↗